White Paper

Reducing Late-Phase Trial Costs, Failures

Source: ICON Plc

Multiple Comparison Procedure – Modelling (MCP-Mod) is a powerful statistical tool that greatly improves the design and analysis of dose finding studies for more accuracy on the targeted dose range. It is deemed “fit-for-purpose” by the FDA after an exhaustive qualification analysis in 2015. MCP-Mod is an “efficient statistical methodology for the model-based design and analysis of dose-finding studies under model uncertainty.

Combined with the adaptive study design, simulation and modelling capabilities of ICON’s ADDPLAN® neo, adaptive MCP-Mod may significantly enhance drug development efficiency. Adaptive MCP-Mod designs help to reduce costs in futile developments programs, while preserving predictive insight in successful development programs, actively supporting early development preparations leading to shortened timelines.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader